ZielBio to Present Interim Findings from its Phase 1/2, First-in-Human Trial of ZB131 at 2023 ASCO Annual Meeting

/PRNewswire/ -- ZielBio, Inc., a clinical stage biotechnology company discovering new treatments for cancer and other serious diseases, will present the first...

Related Keywords

United States ,San Antonio ,Texas ,American ,David Sommerhalder ,Prnewswire Zielbio Inc ,American Society Of Clinical Oncology ,Clinical Oncology ,Alan Bash ,Zielbio ,Nc ,